CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Votivadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03536819
NCT03536819N/ACompleted
CompareCT.gov

Radio-frequency Rejuvenation for Pelvic Floor and Vagina

InMode MD Ltd.·interventional·Posted May 25, 2018·Updated Nov 18, 2020

In Brief

A clinical study evaluating Votiva for Symptoms Associated With Pelvic Floor Weakness. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Evaluation of efficacy and safety of the Votiva RF system with the Forma V handpiece for vaginal treatments.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSymptoms Associated With Pelvic Floor Weakness
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 25, 2018
Enrollment StartNov 17, 2017
Primary CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.1 years ago

Interventions

Votivadevice

The applicator uses radio-frequency energy to treat the vaginal canal